![](/img/cover-not-exists.png)
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy
Cho, Hyungwoo, Yoon, Dok Hyun, Kim, Kyu-pyo, Bae, Kyun-Seop, Kim, Won Seog, Eom, Hyeon-Seok, Kim, Jin Seok, Hong, Jung Yong, Kim, Seok Jin, Lee, Hyewon, Kim, Soo-Jeong, Suh, CheolwonLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0582-0
Date:
March, 2018
File:
PDF, 849 KB
english, 2018